Skip to main content
logo
Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0211
-0.0021 (-8.86%)
Sep 25, 2026, 3:59 PM EST

Bioxytran Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-3.71-1.85-2.23-3.81-2.14-4.21
Net Income
-3.49-2.12-2.37-4.47-2.46-4.03
Earnings Per Share
-0.03-0.02-0.02-0.03-0.02-0.04
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.180.510.010.030.30.07
Total Debt
1.211.251.091.932.172.12
Net Cash (Debt)
-1.03-0.74-1.09-1.9-1.87-2.05
Net Cash Growth
------
Net Cash Per Share
-0.01-0.01-0.01-0.01-0.02-0.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.87-0.53-0.38-0.78-1.81-1.7
Free Cash Flow
-0.87-0.53-0.38-0.78-1.81-1.7
Free Cash Flow Growth
------